南美洲呼吸吸入器市场预测至 2028 年 – COVID-19 影响和区域分析 – 按产品类型 [雾化器、计量吸入器 (MDI) 和干粉吸入器]、技术(手动操作吸入器和数字操作吸入器)和疾病适应症(哮喘、慢性阻塞性肺病、肺动脉高压等)

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2028


No. of Pages: 147    |    Report Code: BMIRE00028400    |    Category: Life Sciences

South America Respiratory Inhalers Market

南美洲呼吸吸入器市场预计将从2022年的27.8432亿美元增长到2028年的36.3645亿美元。预计2022年至2028年的复合年增长率为4.6%。< /span>

越来越多地采用智能吸入器技术,为南美呼吸吸入器市场提供增长机会

智能吸入器旨在帮助哮喘患者通过在智能手机上记录时间和剂量来确保他们按照处方服药。临床医生可以使用收集的数据来验证处方治疗是否有效,个性化哮喘检查以关注症状恶化的根本原因,并提供早期预警系统来告知何时前往诊所。这项技术可以从一刀切的哮喘筛查转变,减少常规预约,从而减轻国家医疗服务体系 (NHS) 的压力。由于呼吸不均匀,成年人和老年人很难吸同样的烟,因为支持呼吸的肌肉和横膈膜随着年龄的增长而减弱,导致他们无法吸入或呼出足够的空气。智能吸入器可以使他们受益。配备传感器的智能吸入器可以连接到传统吸入器,并帮助跟踪服药时间。由于具有蓝牙功能,它们还可以与计算机或智能设备(例如手机或平板电脑)远程配对,以自动从智能吸入器传输数据。因此,智能吸入器的上述应用及其日益普及预计将在未来几年为呼吸吸入器市场提供增长机会。

南美呼吸吸入器吸入器市场概述

南美洲呼吸吸入器市场分为巴西、阿根廷和南美洲其他地区。 2022 年,巴西在南美洲呼吸吸入器市场占据主导地位。无论是按面积还是按人口计算,巴西都是全球第五大国家。与该地区其他国家相比,该国的医疗保健设施和服务更好。它正在经历全球最快的人口老龄化。 2020年,老年人口约3010万人,约占总人口的14.3%。此外,根据巴西统计局的数据,到 2050 年,65 岁及以上的人口预计将达到总人口的 36%。老龄化增加了患各种慢性疾病的可能性。例如,肺部疾病,包括特发性肺纤维化和慢性阻塞性肺病,在老年人中变得更加常见。随着巴西老年人口的增长,导致呼吸系统疾病等各种健康疾病的发病率增加,从而导致对呼吸吸入器的需求增加。所有这些因素都可能推动呼吸吸入器的采用,最终为巴西呼吸吸入器市场提供机会。

南美呼吸吸入器市场收入和 2028 年预测(百万美元)

南美洲呼吸系统吸入器市场细分

南美呼吸吸入器市场根据产品类型、技术、疾病适应症和国家/地区进行细分。

根据产品类型,南美呼吸吸入器市场分为雾化器、定量吸入器 (MDI) 和干粉吸入器。 2022年,干粉吸入器细分市场在南美呼吸吸入器市场中占据最大份额。

根据技术,南美呼吸吸入器市场分为手动操作吸入器和手动操作吸入器。数字操作的吸入器。 2022 年,手动操作吸入器细分市场在南美呼吸吸入器市场中占据较大份额。

根据疾病适应症,南美呼吸吸入器市场细分为哮喘、慢性阻塞性肺病、肺动脉高压等。 2022 年,哮喘细分市场在南美呼吸吸入器市场中占据最大份额。

根据国家/地区,南美呼吸吸入器市场已分为巴西、阿根廷和南美洲其他地区。 2022 年,巴西将主导南美呼吸吸入器市场。

阿斯利康公司; Beximco 制药有限公司;勃林格殷格翰国际有限公司;西普拉有限公司;葛兰素史克公司;皇家飞利浦公司;欧姆龙公司; OPKO 健康公司; PARI 呼吸设备有限公司;和 Teva Pharmaceutical Industries Ltd 是南美呼吸吸入器市场的领先公司。



South America Respiratory Inhalers Strategic Insights

Strategic insights for South America Respiratory Inhalers involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/south-america-respiratory-inhalers-market-strategic-framework.webp
Get more information on this report

South America Respiratory Inhalers Report Scope

Report Attribute Details
Market size in 2022 US$ 2,784.32 Million
Market Size by 2028 US$ 3,636.45 Million
Global CAGR (2022 - 2028) 4.6%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By 产品类型
  • 雾化器
  • 定量吸入器
  • 干粉吸入器
By 技术
  • 手动吸入器和数字吸入器
By 疾病适应症
  • 哮喘
  • 慢性阻塞性肺病
  • 肺动脉高压
Regions and Countries Covered 南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
Market leaders and key company profiles
  • AstraZeneca Plc
  • Beximco Pharmaceuticals Ltd.
  • Boehringer Ingelheim International GmbH
  • Cipla Ltd
  • GSK Plc
  • Koninklijke Philips NV
  • OMRON Corp
  • OPKO Health, Inc
  • PARI Respiratory Equipment, Inc.
  • Teva Pharmaceutical Industries Ltd
  • Get more information on this report

    South America Respiratory Inhalers Regional Insights

    The regional scope of South America Respiratory Inhalers refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/south-america-respiratory-inhalers-market-geography.webp
    Get more information on this report

    The List of Companies - South America Respiratory Inhalers Market

    1. AstraZeneca Plc
    2. Beximco Pharmaceuticals Ltd.
    3. Boehringer Ingelheim International GmbH
    4. Cipla Ltd  
    5. GSK Plc 
    6. Koninklijke Philips NV
    7. OMRON Corp   
    8. OPKO Health, Inc
    9. PARI Respiratory Equipment, Inc.
    10. Teva Pharmaceutical Industries Ltd  
    Frequently Asked Questions
    How big is the South America Respiratory Inhalers Market?

    The South America Respiratory Inhalers Market is valued at US$ 2,784.32 Million in 2022, it is projected to reach US$ 3,636.45 Million by 2028.

    What is the CAGR for South America Respiratory Inhalers Market by (2022 - 2028)?

    As per our report South America Respiratory Inhalers Market, the market size is valued at US$ 2,784.32 Million in 2022, projecting it to reach US$ 3,636.45 Million by 2028. This translates to a CAGR of approximately 4.6% during the forecast period.

    What segments are covered in this report?

    The South America Respiratory Inhalers Market report typically cover these key segments-

  • 产品类型 (雾化器, 定量吸入器, 干粉吸入器)
  • 技术 (手动吸入器和数字吸入器)
  • 疾病适应症 (哮喘, 慢性阻塞性肺病, 肺动脉高压)
  • What is the historic period, base year, and forecast period taken for South America Respiratory Inhalers Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South America Respiratory Inhalers Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2028
  • Who are the major players in South America Respiratory Inhalers Market?

    The South America Respiratory Inhalers Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • AstraZeneca Plc
  • Beximco Pharmaceuticals Ltd.
  • Boehringer Ingelheim International GmbH
  • Cipla Ltd
  • GSK Plc
  • Koninklijke Philips NV
  • OMRON Corp
  • OPKO Health, Inc
  • PARI Respiratory Equipment, Inc.
  • Teva Pharmaceutical Industries Ltd
  • Who should buy this report?

    The South America Respiratory Inhalers Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the South America Respiratory Inhalers Market value chain can benefit from the information contained in a comprehensive market report.